Hans-jurgen J. Gallowitsch
Klagenfurt Am Woerthersee, 9020, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Assessment of Treatment Response to Lenvatinib in Thyroid Cancer Monitored by F-18 FDG PET/CT Using PERCIST 1.0, Modified PERCIST and EORTC Criteria-Which One Is Most Suitable?
Journal: Cancers
Published: February 25, 2022
Impact of the COVID-19 pandemic on nuclear medicine departments in Europe.
Journal: European journal of nuclear medicine and molecular imaging
Published: July 30, 2021
Diagnostic Reference Levels for nuclear medicine imaging in Austria: A nationwide survey of used dose levels for adult patients.
Journal: Zeitschrift fur medizinische Physik
Published: July 23, 2021
Real-World Data for Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer (RELEVANT): A Retrospective Multicentric Analysis of Clinical Practice in Austria.
Journal: International journal of endocrinology
Published: July 30, 2020
Lymphoscintigraphy SPECT/CT: Instrumental Navigator in Repair of Thoracic Duct Injury.
Journal: Nuclear medicine and molecular imaging
Published: December 24, 2014
Treatment of patients with radioiodine refractory, differentiated thyroid carcinoma. A Consensus Statement
Journal: Nuklearmedizin. Nuclear medicine
Published: July 29, 2014
Nuclear medicine and oncology.
Journal: Wiener medizinische Wochenschrift (1946)
Published: October 27, 2012
FDG PET and FDG PET/CT in patients with gastrointestinal stromal tumours.
Journal: Wiener medizinische Wochenschrift (1946)
Published: May 23, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026